Aligos Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €161.63M +109.0% €40.04M -202.7% 24.8% +0.75 pp -€125.98M +17.5% -77.9% +0.61 pp
    (estimated) €77.34M +3,600.8% -€38.98M -59.6% -50.4% +46 pp -€107.22M +20.1% -138.6% +41 pp
    (estimated) €2.09M +15.0% -€96.57M +20.3% -4,621.2% -2.0 pp -€89.30M +10.1% -4,273.5% +1.9 pp
    (estimated) €1.82M -7.0% -€80.30M +535.7% -4,419.7% -38 pp -€81.12M +19.5% -4,464.8% -9.9 pp
    (estimated) €1.95M -42.0% -€12.63M -88.7% -646.7% +27 pp -€67.89M -1.3% -3,476.0% -14 pp
    €3.36M -74.6% -€111.92M +49.6% -3,326.0% -28 pp -€68.76M +2.1% -2,043.4% -15 pp
    €13.25M +11.7% -€74.79M -8.7% -564.6% +1.3 pp -€67.36M +0.7% -508.6% +0.55 pp
    €11.86M +219.0% -€81.92M -25.2% -690.6% +23 pp -€66.91M -31.6% -564.1% +21 pp
    €3.72M +∞% -€109.46M +18.2% -2,944.1% -29 pp -€97.89M +59.0% -2,632.9% -26 pp
    €0.00 +NaN% -€92.58M +107.7% N/A -€61.58M +64.2% N/A
    €0.00 +NaN% -€44.58M +275.1% N/A -€37.51M +1,144.9% N/A
    €0.00 -€11.88M N/A -€3.01M N/A

    Notifications